Journal article

PanCO: Updated Results of an Open-Label, Single-Arm Pilot Study of OncoSil P-32 Microparticles in Combination with Standard-of-Care (SoC) Gemcitabine Nab-Paclitaxel or FOLFIRINOX Chemotherapy in Unresectable Locally Advanced Pancreatic Cancer (uLAPC)

Paul Ross, Alain Hendlisz, Thankamma Ajithkumar, Chinenye Iwuji, Marion Harris, Daniel Croagh, Morteza Aghmesheh, Adnan Nagrial, Nam Nguyen, Mehrdad Nikfarjam, Nicole Wilson, Daniel Kenny, David Turner, Harpreet S Wasan

Pancreatology | Elsevier BV | Published : 2020

University of Melbourne Researchers

Keywords